Full list of genes differentially expressed by 1.5-fold or more in either the vemurafenib-treated or control wounds on day 16.

(A) normalized gene expression, (B) differential expression between the vemurafenib-treated and control wounds on day 16, and (C, D, E, F, G) ENRICHR-based enrichment analysis in the respective gene sets/gene ontology/pathway on genes with at least 1.5-fold expression change in Table B. (XLSX)(A) 标准化基因表达（normalized gene expression），(B) 第16天时经维罗非尼（Vemurafenib）处理的创面与对照创面的差异表达水平，以及(C、D、E、F、G) 针对表B中表达变化倍数至少1.5倍的基因，在对应基因集、基因本体（Gene Ontology，GO）及通路中开展的基于ENRICHR的富集分析。(XLSX)